DE60231385D1 - Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung - Google Patents

Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung

Info

Publication number
DE60231385D1
DE60231385D1 DE60231385T DE60231385T DE60231385D1 DE 60231385 D1 DE60231385 D1 DE 60231385D1 DE 60231385 T DE60231385 T DE 60231385T DE 60231385 T DE60231385 T DE 60231385T DE 60231385 D1 DE60231385 D1 DE 60231385D1
Authority
DE
Germany
Prior art keywords
formulations containing
included ingredients
containing included
ingredients
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231385T
Other languages
English (en)
Inventor
Martin Lotz
Alexander R Shikhman
San-Bao Hwang
Changyong Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Optimer Pharmaceuticals LLC
Original Assignee
Scripps Research Institute
Optimer Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute, Optimer Pharmaceuticals LLC filed Critical Scripps Research Institute
Application granted granted Critical
Publication of DE60231385D1 publication Critical patent/DE60231385D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60231385T 2001-03-29 2002-03-29 Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung Expired - Lifetime DE60231385D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28035101P 2001-03-29 2001-03-29
PCT/US2002/009859 WO2002078445A1 (en) 2001-03-29 2002-03-29 Formulations comprising entrapped active ingredients and uses thereof

Publications (1)

Publication Number Publication Date
DE60231385D1 true DE60231385D1 (de) 2009-04-16

Family

ID=23072710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231385T Expired - Lifetime DE60231385D1 (de) 2001-03-29 2002-03-29 Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung

Country Status (11)

Country Link
EP (1) EP1379135B1 (de)
JP (1) JP2005500991A (de)
CN (1) CN1499929A (de)
AT (1) ATE424111T1 (de)
AU (1) AU2002255993B2 (de)
CA (1) CA2442146A1 (de)
DE (1) DE60231385D1 (de)
ES (1) ES2322985T3 (de)
MX (1) MXPA03008812A (de)
NZ (1) NZ528544A (de)
WO (1) WO2002078445A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1232256C (zh) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在制备治疗自身免疫反应所致的局部损伤或全身症状的药物中的应用
EP1670486A4 (de) * 2003-10-01 2009-04-01 Optimer Pharmaceuticals Inc Behandlung eines zustands in einem säugetier mit verabreichung von aminozucker und verwendungen davon
WO2005051326A2 (en) * 2003-11-24 2005-06-09 Optimer Pharmaceuticals, Inc. Treatment of a condition in a mammal with administration of compounds and methods of use thereof
JP5660561B2 (ja) * 2006-09-28 2015-01-28 ハダシット メディカルリサーチサービセス アンド ディベロップメント リミテッド ジョイント部の潤滑に関するグリセロリン脂質の使用
WO2008150477A2 (en) 2007-05-31 2008-12-11 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health N-acetyl mannosamine as a therapeutic agent
US8765172B2 (en) * 2007-12-10 2014-07-01 Epitarget As Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids
US20130058998A1 (en) * 2011-09-07 2013-03-07 United States Of America As Represented By The Secretary, Department Of Health And Human Services Encapsulated n-acetylmannosamine or n-acetylneuraminic acid to increase sialylation
BR112020003767B1 (pt) * 2017-08-22 2023-10-10 Moebius Medical Ltd Composição farmacêutica que compreende lipossomas e uso da dita composição para tratar dor ou irritação em uma articulação

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1044707B (it) * 1968-10-26 1980-04-21 Rotta Research Lab Procedimento per la preparazione di sali di glucosanina e preparati farmaceutici comprendenti detti sali di glucosamina come agenti attivi
JPS59210013A (ja) * 1983-05-04 1984-11-28 Ajinomoto Co Inc 活性物質含有リポソ−ム
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
DE3602670A1 (de) * 1986-01-29 1987-07-30 Speck Ulrich Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen
US5169636A (en) * 1988-03-17 1992-12-08 Nippon Fine Chemical Co., Ltd. Liposomes
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
JPH04159216A (ja) * 1990-10-22 1992-06-02 Japan Tobacco Inc グルコサミン誘導体を膜材として含有するリポソーム
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
JP3570561B2 (ja) * 1993-07-27 2004-09-29 テルモ株式会社 血管内皮損傷部位を認識する担体

Also Published As

Publication number Publication date
WO2002078445A1 (en) 2002-10-10
NZ528544A (en) 2006-03-31
CN1499929A (zh) 2004-05-26
EP1379135A1 (de) 2004-01-14
EP1379135B1 (de) 2009-03-04
ATE424111T1 (de) 2009-03-15
JP2005500991A (ja) 2005-01-13
CA2442146A1 (en) 2002-10-10
ES2322985T3 (es) 2009-07-03
AU2002255993B2 (en) 2008-05-01
MXPA03008812A (es) 2004-10-15
EP1379135A4 (de) 2005-08-03

Similar Documents

Publication Publication Date Title
WO2003045878A8 (en) 2,w-diaminocarboxylic acid compounds
DE60335797D1 (de) Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
ATE460082T1 (de) Formulierungen, die mitkroverkapselte etherische öle enthalten
DE60237269D1 (de) Kosmetische Zusammensetzungen, die Aminosilikone und Verdickungsmittel enthalten, und deren Verwendungen
FR2840903B1 (fr) Derive de glucose et de vitamine f, compositions le comprenant et utilisations pour ameliorer l'etat des poils et des cheveux
TR200100054T2 (tr) Paroksetin metansülfonat
DE602004019331D1 (de) Mit malonsäuresalzen stabilisierte terpenoid-duftkomponenten
WO2005000248A3 (en) Compositions and methods for skin conditioning
DE60232673D1 (de) Zusammensetzungen, die combretastatin und krebsbekämpfendes mittel enthalten
WO2003066597A3 (en) Guanidino compounds
ATE314084T1 (de) Kahalalid f formulierung
AU2525301A (en) Genus leontopodium plant extract and compositions containing same
DE60231385D1 (de) Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
AR038560A1 (es) Una composicion antitranspirante/ desodorante
AU2001293925A1 (en) Method for obtaining an active principle with immediate skin-tightening effect and resulting active principle
TW200602295A (en) Organic compounds
ITMI20031714A1 (it) Formazioni ad azione antitumorale.
DE60120689D1 (de) Verwendung einer antioxidativen zusammensetzung enthaltend einen extrakt aus mozuku-algen
AU2003236764A1 (en) Fragrance composition
RS50074B (sr) Farmaceutski preparat koji sadrži paracetamol i drotaverin
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
AR006034A1 (es) Una composicion antitranspirante, un sistema antitranspirante que la comprende y la utilizacion de un emoliente en la preparacion de la misma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition